靶点针对疾病信息25(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Erbb2 tyrosine kinase receptor (HER2)
INDICATI
Approved Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Approved Head and neck cancer [ICD-11: 2D42]
INDICATI
Approved Hepatitis virus infection [ICD-11: 1E50-1E51]
INDICATI
Approved Lung cancer [ICD-11: 2C25]
INDICATI
Approved Malignant digestive organ neoplasm [ICD-11: 2C11]
INDICATI
Approved Prostate cancer [ICD-11: 2C82]
INDICATI
Approved Stomach cancer [ICD-11: 2B72]
INDICATI
Phase 3 Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 2/3 Metastatic biliary tract neoplasms [ICD-11: 2C14-2C17]
INDICATI
Phase 2 Brain cancer [ICD-11: 2A00]
INDICATI
Phase 2 Lymphoma [ICD-11: 2A80-2A86]
INDICATI
Phase 2 Ureteral cancer [ICD-11: 2C92]
INDICATI
Phase 2 Urogenital cancer [ICD-11: 2C95-2C9Z]
INDICATI
Phase 1/2 Bladder cancer [ICD-11: 2C94]
INDICATI
Phase 1/2 Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]